Cargando…
Recent progress of nanomedicine in the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common cause of memory disruption in elderly subjects, with the prevalence continuing to rise mainly because of the aging world population. Unfortunately, no efficient therapy is currently available for the AD treatment, due to low drug potency and several challe...
Autores principales: | Hu, Liqiang, Tao, Yiran, Jiang, Yanjiao, Qin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340527/ https://www.ncbi.nlm.nih.gov/pubmed/37457297 http://dx.doi.org/10.3389/fcell.2023.1228679 |
Ejemplares similares
-
Recent Progress of Ferroptosis in Lung Diseases
por: Yu, Shangjiang, et al.
Publicado: (2021) -
Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance
por: Rhaman, Md. Mominur, et al.
Publicado: (2022) -
Recent Progress in the Understanding of the Effect of Sympathetic Nerves on Hair Follicle Growth
por: Zhang, Jiarui, et al.
Publicado: (2021) -
On the Fly: Recent Progress on Autophagy and Aging in Drosophila
por: Maruzs, Tamás, et al.
Publicado: (2019) -
Screening for Core Genes Related to Pathogenesis of Alzheimer’s Disease
por: Yang, Longxiu, et al.
Publicado: (2021)